Netherlands· NL-cd8c7caf2c38

Vagrecor 160 mg filmomhulde tabletten

A valsartan product containing valsartan, registered in Netherlands by Laboratorios Liconsa S.A.. The same ATC class is registered in 19 of our 19 countries.

ATC C09CA03

Checked against CBG-MEB (Netherlands) on September 29, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about valsartanAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Valsartan is registered in 19 of 19 countries.

Countries holding a registration under ATC C09CA03 (valsartan), each read from that country’s own register.

This record: Netherlands, from CBG-MEB (Netherlands)
11 of them publish a price we can compare per daily dose

Search valsartan products by name

Valsartan · ATC C09CA03

19 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Franceprice
Germany
Icelandprice
Ireland
Italyprice
Japan
Netherlands
Norwayprice
Polandprice
Spainprice
Sweden
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of valsartan costs, country by country.

Normalised to the WHO defined daily dose (80 mg), the median price runs from $0.14 in France to $0.56 in Switzerland — a ×4.1 gap.

3 markets with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Valsartan · price per daily dose (80 mg)

USD · FX 28 Sept 2026

CH Switzerland$0.56
IT Italy$0.15
FR France$0.14

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)

Active substance: VALSARTAN
Manufacturer: Laboratorios Liconsa S.A.
Country: Netherlands (NL)
ATC code: C09CA03
ATC class: Valsartan
Defined daily dose: 80 mg, O
Reimbursed: Not published by this register
Source register: CBG-MEB (Netherlands)
Last checked: September 29, 2026

Packs & prices · 1

cbg_meb_id
103976

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

421 interactions on record for valsartan.

Graded by severity as the source publishes them — 7 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check valsartan against other medicines How interaction checks work

Valsartan · interactions on record

421 records

7 severe
128 moderate
205 info

Most severe, free to view

Potassium chlorideA12BA01severe
Potassium citrateA12BA02severe
Potassium gluconateA12BA05severe
Potassium chlorideB05XA01severe

81 more interactions with mechanism and management, from a commercially licensed source.

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Valsartan in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All valsartan products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

Austria · Diovan, Valsacor
Belgium · Diovane, Valsartan Eg
Bulgaria · Suvartar, Валдипин
Cyprus · Codaval, Diovan
Czechia · Blessin, Diovan
Germany · Diovan, Diovan Forte
Denmark · Diovan, Valhelen
Estonia · Diovan, Valsacor
Spain · Diován, Diován Cardio
Finland · Diovan, Valsarstad
France · Tareg, Valsartan Arrow Lab
United Kingdom (Northern Ireland) · Diovan, Valsartan
Greece · Avalsan, Diosartan
Croatia · Diovan, Val
Hungary · Diovan, Tensart
Ireland · Diovan, Valsartan Krka
Iceland · Diovan, Docartan
Italy · Alsartir, Pressloval
Lithuania · Diovan, Suvartar
Luxembourg · Diovane, Valsartan Eg
Latvia · Diovan, Valsacor
Malta · Diovan, Valsaben
Norway · Diovan, Valsartan Actavis
Poland · Aurovalsart, Avasart
Portugal · Diovan, Valsartan Alter
Romania · Diovan, Valsacor
Sweden · Angiosan, Diovan
Slovenia · Diovan, Valsacor
Slovakia · Diovan, Valsacor

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/db18fe4f-f9fa-44dc-8122-a5cdce9aa7e6
GET /v1/drugs/db18fe4f-f9fa-44dc-8122-a5cdce9aa7e6?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Filmomhulde tablet",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h103976_smpc.pdf",
  "strength": null,
  "atc_label": "Valsartan",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg103976",
  "excipients": [
    "CELLULOSE, MICROKRISTALLIJN (E 460(i))",
    "CROSPOVIDON (E 1202)",
    "HYPROMELLOSE (E 464)",
    "IJZEROXIDE  BRUIN (E 172)",
    "IJZEROXIDE GEEL (E 172)",
    "LACTOSE 1-WATER",
    "MACROGOL 4000",
    "MAGNESIUMCARBONAAT, ZWAAR (E 504 (II))",
    "MAÏSZETMEEL, GEPREGELATINEERD",
    "NATRIUMLAURILSULFAAT",
    "NATRIUMSTEARYLFUMARAAT",
    "POVIDON K 25 (E 1201)",
    "SILICIUMDIOXIDE (E 551)",
    "SORBITOL (E 420)",
    "TITAANDIOXIDE (E 171)"
  ],
  "substances": [
    "VALSARTAN"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h103976.pdf",
  "authorised_at": "2011/01/18",
  "procedure_number": "NL/H/1590/003",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "103976",
  "additional_monitoring": "N"
}

API reference MCP server Plans

See everything about valsartan.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console